AIDS and Legal Access to Sterile Drug Injection Equipment
The Annals of the American Academy of Political and Social SciencePublished 1 May 1992
Don C. Des Jarlais, Samuel R. Friedman
Citations50
SJR quartileQ1
SJR score1.25
SNIP1.35
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Different techniques of providing legal access—over-the-counter sales and syringe exchanges—research design issues relevant to evaluating legal-access programs, and the findings are consistent in showing no increase in illicit drug use related to legal access and decreases in AIDS risk behaviorrelated to legal- access programs.
Abstract
Legal access to sterile injection equipment has been a primary strategy for preventing the acquired immune deficiency syndrome (AIDS) among persons who inject illicit drugs in almost all developed countries. This strategy has remained highly controversial in the United States, with only a small number of localities adopting it. This article reviews different techniques of providing legal access—over-the-counter sales and syringe exchanges—research design issues relevant to evaluating legal-access programs, and the findings from the large number of studies conducted to date. The findings are consistent in showing no increase in illicit drug use related to legal access and decreases in AIDS risk behavior related to legal-access programs. The design of legal-access programs for maximal impact and the ultimate effect of the decreases in AIDS risk behavior on transmission of the human immunodeficiency virus (HIV) remain to be determined.
Keywords
Social SciencesMedicine
Population and Development ReviewAIDS: Sexual Behavior and Intravenous Drug Use.
340 Citations1989John Bongaarts, Charles F. Turner +2 more
The US Committee on AIDS Research and the Behavioral Social and Statistical Sciences was asked to describe what is known about the spread of HIV and AIDS in the US with special attention to the quality of information at hand and the kind of additional information that is needed.
JAMAHIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987
328 Citations1989Don C. Des Jarlais
BMJEpidemic of AIDS related virus (HTLV-III/LAV) infection among intravenous drug abusers.
309 Citations1986J R Robertson, A B Bucknall +5 more
The practice of sharing needles and syringes correlated with seropositivity, which, combined with the almost exclusive intravenous use of heroin and other behavioural patterns, may explain the high prevalence of HTLV-III/LAV infection in the area.
Annals of Internal MedicineRisk Reduction for the Acquired Immunodeficiency Syndrome Among Intravenous Drug Users
254 Citations1985Don C. Des Jarlais, Samuel R. Friedman +1 more
There has been a sustained increase in the demand for new, unused needles, as shown in the emergence of "resealed" needles and in interviews with persons selling needles in illicit drug-purchasing areas.
JAMAHIV-1 Infection Among Intravenous Drug Users in Manhattan, New York City, From 1977 Through 1987
235 Citations1989Don C. Des Jarlais
Seroprevalence rates among intravenous drug users in the borough of Manhattan stabilized between 55% and 60% from 1984 through 1987, and this relatively constant rate is attributed to new infections, new seronegative persons beginning drug injection, seropositive persons leavingdrug injection, and increasing conscious risk reduction.
International Journal of the AddictionsAIDS and Self-Organization among Intravenous Drug Users
208 Citations1987Samuel R. Friedman, Don C. Des Jarlais +4 more
Data is presented indicating that gay individuals have more risk-reducing behavioral changes than have i.v. drug users, and it is suggested that collective self-organization can lead to peer support for risk reduction and that this can help i.V.drug users to reduce their risks on an ongoing basis.
ScienceA Larger Spectrum of Severe HIV-1—Related Disease in Intravenous Drug Users in New York City
189 Citations1988Rand Stoneburner, Don C. Des Jarlais +8 more
Investigations of these deaths suggest a causal association with human immunodeficiency virus (HIV) infection and may represent a spectrum of HIV-related disease that has not been identified through AIDS surveillance and has resulted in a large underestimation of the impact of AIDS on IV drug users and blacks and Hispanics.
American Journal of Public HealthRisk reduction among intravenous drug users in Amsterdam under the influence of AIDS.
112 Citations1989J A van den Hoek, H J van Haastrecht +1 more
It is concluded that ample provision of needles and syringes is an important starting point but in itself not enough to produce the necessary drastic change in risk behavior and intensive counseling of the drug user is also needed.
PubMedKnowledge about AIDS and high-risk behavior among intravenous drug users in New York City.
102 Citations1987Selwyn Pa, Cheryl Feiner +3 more
Results suggest that certain subgroups of IV drug users have adopted risk-reduction measures in response to AIDS, and expanded educational programs, increased drug treatment capacity, and additional strategies addressing drug users' access to sterile injection equipment and the social context of needle-sharing may be necessary to curb the further spread of AIDS.
AIDSEvaluation of needle exchange in central London
93 Citations1989Graham Hart, Andrea Carvell +4 more
The scheme attracts clients, reduces injecting-related risk for HIV infection and has high equipment return rates, and Saliva testing is acceptable to clients.
JAIDS Journal of Acquired Immune Deficiency SyndromesHIV Prevention Among Injecting Drug Users
72 Citations1991Bengt Ljungberg, Bértil Christensson +5 more
The seroprevalence for HIV among drug users in south Sweden has been maintained at approximately 1% in contrast to up to 60% in subpopulations from other Scandinavian regions with a comparable drug problem.
New England Journal of MedicinePrevalence of Antibody to Lymphadenopathy-Associated Virus among Drug-Detoxification Patients in New York
69 Citations1984T J Spira, D. C. Des Jarlais +7 more
Seropositive non-AIDS intravenous drug abusers from this series are being followed to determine which will acquire immunosuppression-related disease.
AIDSHIV status and changes in risk behaviour among intravenous drug users in Stockholm 1987–1988
62 Citations1990Kerstin Käll, Robert Olin
An HIV study initiated in January 1987 is being conducted at the Remand Prison in Stockholm, Sweden, in order to follow HIV seroprevalence and HIV risk behaviour among intravenous drug users (IVDUs) in Stockholm.
PubMedHIV infection among persons who inject illicit drugs: problems and prospects.
58 Citations1988Don C. Des Jarlais, Samuel R. Friedman
Preliminary studies from New York City, San Francisco, and Stockholm indicate a relative stabilization of seroprevalence in these cities, suggesting that the behavior changes reported in those cities may be significantly slowing the rate of viral spread.
American Journal of Public HealthThe course of the HIV epidemic among intravenous drug users in Amsterdam, The Netherlands.
57 Citations1991H J van Haastrecht, J A van den Hoek +3 more
It is concluded that changes in drug use behavior so far appear to have resulted in a stabilization of the epidemic among injectors, at a level with a still disturbingly high incidence rate of 5-6 per 100 person-years.
Health PolicyConfronting AIDS. Directions for public health, health care and research
56 Citations1987Jan Desmyter
British Journal of AddictionThe sharing of injecting equipment among drug users attending prescribing clinics and those using needle‐exchanges
49 Citations1991Hilary Klee, Jean Faugier +2 more
Three groups of injecting drug-users were defined in terms of their experience of methadone treatment: treatment for periods longer than 6 months, treatment for shorter periods, and no treatment, which suggested respondents in long-term treatment were less likely to pass on their equipment than those in the other two groups.
AIDSSyringe HIV seroprevalence and behavioural and demographic characteristics of intravenous drug users in Sydney, Australia, 1987
41 Citations1988Jael Wolk, Alex Wodak +5 more
PubMedThe effects of the liberalization of syringe sales on the behaviour of intravenous drug users in France.
17 Citations1989Ingold Fr, Sylvie Ingold
The authors concluded that the decision to make syringes freely available for sale was not, by itself, sufficient to cope with the syringe-sharing problem and that appropriate educational programmes, personalized and geared to each subject's special circumstances, needed to be provided.
European Journal of Cancer and Clinical OncologyTrends of HTLV-I and HIV infections in drug addicts
16 Citations1988Anita De Rossi, Flavia Bortolotti +2 more